Progress Towards a Midlife Risk Score for Decline in Women’s Physical Health and Function

Doctor sits with female patient, holding a clipboard and pen

Daniel H. Solomon, MD, MPH, and colleagues have examined data from the Study of Women’s Health Across the Nation to identify several risk factors that might form the basis of a clinically useful risk score, which may point to preventive or therapeutic midlife interventions.

Read More...

Meta-analysis: Effect of EPA vs. EPA+DHA Omega-3 Fatty Acids on Cardiovascular Outcomes

Deepak L. Bhatt, MD, MPH, of the Interventional Cardiovascular Program at Brigham, and colleagues, recently performed a systematic review and meta-analysis and report that prescription EPA treatment, and not EPA+DHA supplementation, is associated with reductions in cardiovascular mortality and related outcomes.

Read More...

Interest in COVID-19 Vaccination High Among Patients With Systemic Rheumatic Disease

Doctor administers COVID-19 vaccine to patient

Daniel H. Solomon, MD, MPH, Sara K. Tedeschi, MD, MPH, and colleagues surveyed patients with systemic rheumatic disease (SRD) about their attitudes toward COVID-19 vaccination. They report high interest and a high trust in physician recommendations about vaccination.

Read More...

Case Report: Carotid Blowout With Massive Epistaxis in Patient With Skull Base Osteomyelitis

MRI non-contrast angiography of neck vessels, including internal carotid artery

A 77-year-old woman, whose past medical history included type 2 diabetes, end-stage renal disease and hypertension, presented to the emergency department with a two-month history of severe left ear and facial pain. Imaging demonstrated changes in soft tissue and bone that were concerning for skull base osteomyelitis.

Read More...

“Self-tunable” Engineered Yeast Probiotics May Allow Precision Treatment of IBD

Francisco J. Quintana, PhD, Cristina Gutiérrez-Vázquez, PhD, and colleagues engineered yeasts that generate an immunosuppressive molecule in direct proportion to the amount of a pro-inflammatory metabolite produced in the inflamed gut. They describe their new treatment platform and the results.

Read More...

Cardiac Risk Substantially Lower with Enzalutamide Than Abiraterone

Using the world’s largest pharmacovigilance database, Eugene B. Cone, MD, Quoc-Dien Trinh, MD, and colleagues determined the risk of cardiac adverse events is increased substantially with abiraterone and not at all with enzalutamide.

Read More...

Adapted Frailty Index Feasible for Use by Geriatricians Across Multiple Clinical Services

Electronic medical record on a tablet.

Lisa Cooper, MD, and Houman Javedan, MD, of the Division of Aging at the Brigham, and colleagues have adapted the comprehensive geriatric assessment (FI-CGA) tool to be feasible for use by geriatricians to communicate complex geriatric concepts with multiple other clinics at the Brigham that care for older adults.

Read More...

Polypharmacy in Older Adults Not Associated with Post-Thoracic Surgery Complications

Close up of senior woman holding a medicine box and taking out a pill

A retrospective study at the Brigham, led by Lisa Cooper, MD, and Laura N. Frain, MD, MPH, found that polypharmacy, potentially inappropriate medications, and frailty were not associated with complications after surgery for thoracic malignancies, but frailty was associated with increased length of hospital stay.

Read More...

Examining the Impact of Carbohydrate Overfeeding on Metabolic Dysfunction

Close up of processed foods like pretzels, cookies, potato chips

By studying how cells from healthy normal weight and overweight participants broke down carbohydrates in real time, researchers including Brigham obesity medicine specialists Nawfal W. Istfan, MD, PhD, and Caroline M. Apovian, MD, have uncovered clues about what triggers metabolic distress.

Read More...

Pulmonary Microbiome May Identify Patients With High-risk Lymphangioleiomyomatosis

CT Scan of a patient with LAM

Souheil Y. El-Chemaly, MD, and Julie Ng, MD, of Brigham and Women’s Hospital, and colleagues conducted the first study to examine the lung microbiome of patients with lymphangioleiomyomatosis (LAM) who were at high risk of disease progression or death.

Read More...